News

1 - 5 of 63

06.05.2008
ChemDiv extends multiyear collaboration with Schering-Plough Corp.

SAN DIEGO, CA - ChemDiv announced today the continuation of a multi-year collaboration with Schering-Plough Corporation.

05.22.2008
ChemDiv announces new BSL-2 Laboratory

San Diego, CA - ChemDiv, Inc. announced today the completion of a new BSL-2 laboratory facility. The new lab and supporting services, located at ChemDiv’s headquarters in San Diego, will be dedicated to antiviral drug discovery and development. The facility is scheduled to be commissioned by July 2008.

05.14.2008
Seminar with Federal Department of Intellectual Property, patents and trade marks

Joint seminars of High Tech Center CHEMRAR and Federal Institute of Industrial Property (Federal Department of Intellectual Property, patents and trade marks (ROSPATENT)).
“State-of-the-art approaches to development of new drugs. Features of IP-protection for “living systems” as objects of medicine.
14th May 2008

04.28.2008
Syndexa Pharmaceuticals and ChemDiv announce discovery collaboration

San Diego, CA – Cambridge, MA – [04.28.08] - ChemDiv, Inc., a global CRO for drug discovery & development, and Syndexa Pharmaceuticals Corporation, a biopharmaceutical company developing first-in-class drugs for the treatment of metabolic diseases, have announced today the signing of a collaborative discovery research agreement.

03.11.2008
ChemDiv and eMolecules announce a customer appreciation discount

In appreciation for their customers ChemDiv and eMolecules are announcing a temporary 25% price reduction for the stock available compounds purchased through the eCommerce service. The offer is valid for 1-200 compound orders purchased at www.chemdiv.emolecules.com in the period of March 15 through April 15, 2008.

1 - 5 of 63